Vircell

Vircell

Granada, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Vircell is an established, privately-held diagnostics company with nearly 30 years of experience in infectious disease testing. It has built a diversified product portfolio spanning traditional serology and modern molecular diagnostics, with a strong international commercial footprint. The company is currently emphasizing growth through its molecular quality control solutions (AMPLIRUN®) and laboratory automation (VirClia® Lotus), positioning itself as a comprehensive provider for diagnostic labs. Its sustained revenue generation is supported by a wide range of ready-to-use kits for bacterial, viral, fungal, and parasitic infections.

Infectious Diseases

Technology Platform

Multi-methodology diagnostics platform encompassing serological assays (ELISA, IFA, CLIA via VirClia® Lotus) and molecular diagnostics (real-time PCR kits and independent molecular controls - AMPLIRUN®).

Funding History

1
SeedUndisclosed

Opportunities

The growing global demand for diagnostic quality control and laboratory accreditation drives the market for its AMPLIRUN® molecular controls.
Expansion of its automated VirClia® Lotus system and test menu can capture share in the high-value automated serology segment, especially in labs seeking flexible, low-volume testing.

Risk Factors

Intense competition from large, multinational IVD corporations with greater resources poses a significant challenge.
The company is also subject to regulatory risks across multiple geographies and potential supply chain disruptions for its broad reagent portfolio.

Competitive Landscape

Vircell competes in a fragmented but competitive global diagnostics market, facing off against large players like Abbott, Roche, and bioMérieux in serology and molecular diagnostics, as well as specialized control manufacturers. Its differentiation lies in its focused infectious disease expertise, broad pathogen menu, and combination of serology with molecular QA controls.